Rethinking Treatment Intensification in Poorly Chemosensitive Ovarian Cancer

Дата публикации: 01-10-2026 00:00:00

This Review examines the rationale, current evidence, and emerging strategies for systemic treatment intensification, or chemosensitization, aimed at improving tumor response before initiating maintenance therapy for advanced high-grade serous ovarian cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
2	Team finds way to reverse ovarian cancer’s chemo resistance	5	8	25-06-2026
3	Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer	0	7.64	01-10-2024
4	Beyond Tumor Size, Toward Meaningful Patient Outcomes	0	8.26	08-10-2026
5	Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer	0	14.28	01-01-2025
6	Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer	0	10	28-07-2026
7	Rethinking Value in Cancer Care in the US	0	5.62	01-10-2026
8	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer	0	18.85	30-07-2026
9	Современные подходы и возможности в выборе терапии ALK+ НМРЛ	0	10.06	21-01-2026
10	Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases	0	7	03-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.84. Источник: jamanetwork.com.